Abstract
Background: The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM), the DSM- 5, was approved by the Board of Trustees of the American Psychiatric Association (APA) on December 1, 2012, and released on May 18, 2013. The DSM-5 is the first major edition of the manual in nearly twenty years. Although designed for use in the United States, the DSM diagnostic system is widely used around the world.
Objectives: To summarize the changes to the overall structure and conceptualization of the DSM-5.
Methods: The author reports on information disseminated at training sessions for psychiatrists representing their District Branches held at the APA’s 2013 Annual Meeting. This is the first in a series of articles that will describe and explain the changes introduced into the DSM-5. This article focuses on the “metastructure” of the DSM-5.
Conclusions: The DSM-5 differs in many fundamental ways from previous versions of the manual, and reflects an ongoing attempt to bring psychiatry into the mainstream of medicine as well as to adapt to anticipated continuing rapid changes within the field.
Keywords: DSM-5; American psychiatric association, diagnostic and statistical manual, psychiatric disorders, diagnosis, classification.
Adolescent Psychiatry
Title:In Transitional Space: A Whirlwind Tour of the DSM-5
Volume: 3 Issue: 4
Author(s): Carlene MacMillan
Affiliation:
Keywords: DSM-5; American psychiatric association, diagnostic and statistical manual, psychiatric disorders, diagnosis, classification.
Abstract: Background: The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM), the DSM- 5, was approved by the Board of Trustees of the American Psychiatric Association (APA) on December 1, 2012, and released on May 18, 2013. The DSM-5 is the first major edition of the manual in nearly twenty years. Although designed for use in the United States, the DSM diagnostic system is widely used around the world.
Objectives: To summarize the changes to the overall structure and conceptualization of the DSM-5.
Methods: The author reports on information disseminated at training sessions for psychiatrists representing their District Branches held at the APA’s 2013 Annual Meeting. This is the first in a series of articles that will describe and explain the changes introduced into the DSM-5. This article focuses on the “metastructure” of the DSM-5.
Conclusions: The DSM-5 differs in many fundamental ways from previous versions of the manual, and reflects an ongoing attempt to bring psychiatry into the mainstream of medicine as well as to adapt to anticipated continuing rapid changes within the field.
Export Options
About this article
Cite this article as:
MacMillan Carlene, In Transitional Space: A Whirlwind Tour of the DSM-5, Adolescent Psychiatry 2013; 3 (4) . https://dx.doi.org/10.2174/221067660304140121172925
DOI https://dx.doi.org/10.2174/221067660304140121172925 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Modeling of Substances Isolated from the Essential Oil of the Species <i>Drimys angustifolia</i> and <i>Drimys brasiliensis</i>
Current Physical Chemistry Molecular Targets of Tannic Acid in Alzheimer's Disease
Current Alzheimer Research The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature
Current Pharmaceutical Design Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Drugs and Medicines in Pregnancy: The Placental Disposition of Opioids
Current Pharmaceutical Biotechnology Adult Changes in Thought Study: Dementia is an Individually Varying Convergent Syndrome with Prevalent Clinically Silent Diseases that may be Modified by Some Commonly Used Therapeutics
Current Alzheimer Research High Dose Immunoglobulin (IVIG) May Reduce the Incidence of Langerhans Cell Histiocytosis (LCH)-Associated Central Nervous System Involvement
CNS & Neurological Disorders - Drug Targets Homochiral Drug Design and Development by Racemization
Combinatorial Chemistry & High Throughput Screening Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences
Current Cardiology Reviews Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of <i>Cannabis sativa</i> in Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Pharmacophore, Similarity and ADMET Screening of Casein Kinase 1 inhibitors in Alzheimer's Disease
Current Bioactive Compounds Interaction of Human Brain Acetylcholinesterase with Cyclophosphamide: A Molecular Modeling and Docking Study
CNS & Neurological Disorders - Drug Targets Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Current Medicinal Chemistry Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Current Pharmaceutical Design LECTURES
Adolescent Psychiatry Mice in Ecstasy: Advanced Animal Models in the Study of MDMA
Current Pharmaceutical Biotechnology Serum β-Amyloid Peptide Levels Spike in the Early Stage of Alzheimer- Like Plaque Pathology in an APP/PS1 Double Transgenic Mouse Model
Current Alzheimer Research Jatrorrhizine Protects Against Okadaic Acid Induced Oxidative Toxicity Through Inhibiting the Mitogen-Activated Protein Kinases Pathways in HT22 Hippocampal Neurons
CNS & Neurological Disorders - Drug Targets Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry An Overview of Olive Oil Biomolecules
Current Biotechnology